top of page

MORE ON

RELATED

ASX Biotech Stocks Working on Cancer, Ranked by Size, Stage and Cash

14 hours ago
21 min read

Samso counted 26 ASX biotech stocks working on treating or finding cancer, and the largest, Telix, is worth more than twice the other ranked companies combined. Most are micro caps, and many are still in early trials. Ten had less than two quarters of cash at 30 September 2026, and most of those have topped up since. For many of the smaller ones, the next trial result and the next capital raising are likely to come close together.

Want to read more?

Subscribe to samso.com.au to keep reading this exclusive post.

bottom of page